Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Adastra Holdings Ltd C.XTRX

Alternate Symbol(s):  XTXXF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Adastra Holdings Ltd. is a Canada-based company, which is engaged in the supply and manufacturing of ethnobotanical and cannabis products for lawful adult-use. The Company extracts and processes cannabis for sale to the recreational and medical markets in Canada using its large-scale extraction facility (the Facility) to produce a variety of products, including vape pens, wax, resin, infused... see more

Recent & Breaking News (CSE:XTRX)

Adastra to Defend Lawsuit

Accesswire March 15, 2023

Adastra Holdings (CSE:XTRX) facing proposed class-action lawsuit

John Ballem  March 13, 2023

This company's shares plummet in the midst of cocaine controversy

Jocelyn Aspa March 6, 2023

Adastra Labs Clarifies and Retracts Certain Disclosure Related to its Receipt of Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Licence

Accesswire March 3, 2023

Adastra Holdings (CSE:XTRX) receives Health Canada approval to produce cocaine

John Ballem  March 3, 2023

Adastra Labs Receives Health Canada Approval for the Amendment to Include Cocaine Under its Controlled Substances Dealer's License

Accesswire February 22, 2023

Leadership Update: Adastra Appoints Lachlan McLeod as CFO

Accesswire February 14, 2023

Adastra Completes Transaction to Terminate Legacy Supply Agreement, Bringing Phyto Extractions Brand 100% In-House

Accesswire February 9, 2023

Adastra Holdings Reports Third Quarter Results; Demonstrating Third Consecutive Quarter of Record Revenue

Accesswire December 1, 2022

Adastra Holdings (CSE:XTRX) receives Controlled Drugs and Substances Dealer's License

John Ballem  September 1, 2022

Adastra Receives Controlled Substances Dealer's License

Accesswire August 31, 2022

Adastra Holdings Reports Record Second Quarter Results; Momentum Accelerating in Second Half of the Year

Accesswire August 26, 2022

Adastra Holdings Continues to Execute on Transformational Strategy; New Product Launches; Outlines Growth Strategy

Canada NewsWire June 29, 2022

Adastra Holdings Reports First Quarter Results

Canada NewsWire May 30, 2022

Adastra Holdings Announces New Director

Canada NewsWire May 16, 2022

Adastra announces 2021 Annual Financial Results and Corporate Update

Stockhouse Editorial May 5, 2022

Adastra Holdings Announces 2021 Annual Financial Results and Corporate Update

Canada NewsWire May 4, 2022

The StockTalk Cannabis Report: April 15, 2022

Dave Jackson April 15, 2022

Adastra announces submission of medical sales license application

Stockhouse Editorial April 12, 2022

Adastra Announces Submission of Medical Sales License Application and Engagement of IR Labs Inc. to Provide Investor Relations Services

Canada NewsWire April 11, 2022